The direct answer — yes
Stress-induced gastritis is genuine mucosal inflammation driven by cortisol. It is not a functional label for patients whose endoscopy is normal — that is a separate entity (functional dyspepsia). Real stress gastritis involves endoscopic changes, NF-kB-driven cytokine production, and the same EGFR/ERK repair suppression that H. pylori causes.
Cortisol's two NF-kB activation pathways
Cortisol binds glucocorticoid receptors (GR) in gastric epithelial cells. Activated GRs can promote NF-kB nuclear translocation through a non-canonical signalling pathway — activating NF-kB even though glucocorticoids are classically considered anti-inflammatory at immune cell level. In the gastric epithelium specifically, sustained cortisol drives NF-kB-mediated cytokine production.
Direct pathwayCortisol suppresses COX-1 and COX-2 enzymes that maintain prostaglandin production. Prostaglandins support superoxide dismutase (SOD) and catalase — the primary antioxidant defences in gastric epithelial cells. With antioxidant defences compromised, reactive oxygen species (ROS) accumulate. ROS activates NF-kB through oxidative stress signalling — a second, parallel NF-kB activation pathway.
Oxidative pathwayBoth cortisol pathways produce NF-kB activation in gastric epithelial cells. NF-kB drives IL-6, IL-8, and TNF-α production — the same pro-inflammatory cytokines H. pylori's CagA and LPS activate. The downstream mucosal damage (thinning, EGFR/ERK suppression, inflammatory cell infiltration) is structurally identical. The upstream trigger is different; the tissue pathology is the same.
ConvergenceHow stress gastritis differs from H. pylori gastritis
| Feature | Stress Gastritis | H. Pylori Gastritis |
|---|---|---|
| NF-kB activation source | Cortisol (GR signalling + ROS) | CagA injection + LPS-TLR4 binding |
| Activity pattern | Episodic — tied to stress periods | Continuous — until eradication |
| EGFR/ERK suppression | ✓ Yes — via NF-kB | ✓ Yes — via NF-kB |
| Endoscopy findings | Erythema, oedema, erosions in genuine cases | Erythema, erosions, mucus depletion |
| Resolution pathway | Stress reduction + NF-kB inhibition + EGFR/ERK repair | H. pylori eradication + EGFR/ERK repair |
| Persists when trigger removed? | Mucosal damage persists — needs active repair | NF-kB continues until eradicated |
Real stress gastritis vs functional dyspepsia
Not every patient with stress-related gut symptoms has genuine gastritis. Two presentations exist:
Type 1 — Genuine stress-induced gastritis: Real NF-kB-mediated mucosal inflammation. Endoscopy shows erythema, oedema, and in sustained cases erosions. Responds to NF-kB inhibition and EGFR/ERK repair support alongside stress management.
Type 2 — Functional dyspepsia labelled as stress gastritis: Normal or near-normal endoscopy despite significant symptoms. ENS hypersensitivity and visceral hyperalgesia — the gut processes normal signals as pain. Symptoms are real but the tissue pathology is different. Treatment focus shifts to ENS regulation (mebeverine, gut-directed therapy) rather than mucosal repair.
Before attributing gastric symptoms entirely to stress — whether with or without endoscopic changes — H. pylori should be tested and treated if present. In India's 62% symptomatic H. pylori population, stress is almost never the only factor. The patient whose symptoms correlate with stress periods may be identifying the compounding factor rather than the primary cause.
References
- Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380:1158–1165. PMID 30699316. NF-kB downstream pathway — the convergent mechanism shared by cortisol and H. pylori that produces identical tissue pathology from different upstream triggers.
- Ye YN et al. Licorice flavonoids and gastric mucosal repair via EGFR/ERK pathway. Journal of Ethnopharmacology. 2023;302:115866. PMID 36842733. EGFR/ERK repair activation — the mechanism required to address the repair deficit that both stress and H. pylori produce.
- Merlin Annie Raj, RD. TumGard India Gut Health Report 2026. Hugg Beverages Pvt. Ltd. 2026. tumgard.com/india-gut-health-report-2026. India-specific H. pylori prevalence context — the 62% co-prevalence in symptomatic patients that makes H. pylori exclusion essential before stress attribution.